Farnes, I.; Verbeke, C.S.; Kleive, D.; Waage, A.; Tholfsen, T.; Hagen, M.; Fosby, B.; Line, P.-D.; Labori, K.J.
Surgical, Histopathological, and Quality of Life Outcomes Following Neoadjuvant Chemotherapy and Pancreatectomy for Borderline Resectable and Locally Advanced Pancreatic Cancer. Cancers 2025, 17, 2505.
https://doi.org/10.3390/cancers17152505
AMA Style
Farnes I, Verbeke CS, Kleive D, Waage A, Tholfsen T, Hagen M, Fosby B, Line P-D, Labori KJ.
Surgical, Histopathological, and Quality of Life Outcomes Following Neoadjuvant Chemotherapy and Pancreatectomy for Borderline Resectable and Locally Advanced Pancreatic Cancer. Cancers. 2025; 17(15):2505.
https://doi.org/10.3390/cancers17152505
Chicago/Turabian Style
Farnes, Ingvild, Caroline S. Verbeke, Dyre Kleive, Anne Waage, Tore Tholfsen, Milada Hagen, Bjarte Fosby, Pål-Dag Line, and Knut Jørgen Labori.
2025. "Surgical, Histopathological, and Quality of Life Outcomes Following Neoadjuvant Chemotherapy and Pancreatectomy for Borderline Resectable and Locally Advanced Pancreatic Cancer" Cancers 17, no. 15: 2505.
https://doi.org/10.3390/cancers17152505
APA Style
Farnes, I., Verbeke, C. S., Kleive, D., Waage, A., Tholfsen, T., Hagen, M., Fosby, B., Line, P.-D., & Labori, K. J.
(2025). Surgical, Histopathological, and Quality of Life Outcomes Following Neoadjuvant Chemotherapy and Pancreatectomy for Borderline Resectable and Locally Advanced Pancreatic Cancer. Cancers, 17(15), 2505.
https://doi.org/10.3390/cancers17152505